Professional Documents
Culture Documents
HYDRONEPHROSIS
DIFFERENTIAL DIAGNOSIS
AHN can be diagnosed and graded based on the transfers plane measurement
of anteroposterior diameter (APD) of the fetal renal pelvis
US at 16-20 weeks gestation should include evaluation for lower urinary tract obstruction
renal dysplasia and extrarenal structural malformations
ANTENATAL HYDRONEPHROSIS
COURSE
30% of patients with moderate or severe ANH persisting in the third trimester
require postnatal surgery
The risk in utero worsening is higher for bilateral than for unilateral disease
For fetuses with AHN imaging should be repeated every 4-6 weeks or more frequently
depending on the severity of HN, or the presence of findings suggestive of lower urinary
tract obstruction such as dilated bladder and ureters and/or oligohydramnos
27th week
BILATERAL AHN
35th week
POSTERIOR URETRAL VALVE
98% of patients with APD<10 mm had mild or resolved dilation on postnatal evaluation
APD 10–20 mm corresponded to improvement in 80% or persistent moderate HN postnatally in 20% of patients
The rate of postnatal pathology increased with the degree of pelvic dilatation ranging from 12% for mild, 45% for moderate
to 88% for severe HN. This relation was evident for patients with PUV or UPJO but not VUR or UVJO
UPJO
VUR
PUV
PUV demonstrates bilateral hydroureteronephrosis with a thick walled bladder and keyhole sign in the bladder
neck of males on the second trimester US
POSTNATAL EVALUATION
No universal guidelines for the clinical management of patients with mild to moderate AHN are
currently available
Antero-posterior diameter (APD) measurements of the renal pelvis and Society for Fetal
Urology (SFU) grades are the two most-commonly used grading systems for AHN
Postnatal US should include evaluation for calyceal or ureteric dilation, cortical cysts and
enhanced renal echogenicity, ureterocel and bladder wall abnormalities and bladder emptying
ANTENATAL HYDRONEPHROSIS
The risk of postnatal pathology increased with the degree of antenatal pelvic
dilatation (12% for mild, 45% for moderate and 88% for severe HN)
The grading system of Society for Fetal Urology for postnatal HN is based on US findings
of the degree of renal-pelvic & calyceal dilation and takes into account the integrity of the parenchyma.
Grade 0 is normal and not represented in the figure
SFU Grade 2
SFU Grade 3
SFU Grade 4
ANTENATAL HYDRONEPHROSIS
The risk of postnatal pathology increased with the degree of antenatal pelvic dilatation
(12% for mild, 45% for moderate and 88% for severe HN)
Patients with SFU grade 1 or 2 hydronephrosis or postnatal APDs <20mm are at low risk
for significant pathology, renal deterioration and a subsequent need for surgery
Prophylactic antibiotics and complete evaluation are needed for patients with SFU grade
4 hydronephrosis or APDs >30 mm
Progression to renal deterioration and need for surgery in patients with SFU grade 3 or
bilateral grade 2 hydronephrosis (or APDs 20–30 mm) is unclear with APD>40mm
All newborns with history of AHN (including those in whom it had resolved prenatally) should have
postnatal US examination at the end of the first week of life (3-7days )
before the hospital discharge
Neonates with normal ultrasound examination in the first week of life should
undergo a repeat US examination at 4-6 weeks
Infants with isolated mild unilateral or bilateral HN (APD <10 mm or SFU grade 1-2) should be
followed by sequential ultrasound alone, for resolution or progression of findings
VESICOURETERAL REFLUX
VUR is present in 8-38% patients with AHN, as compared to <1% in the general population
Although there is increased risk of UTI, there is lack of evidence that antibiotic prophylaxis in
patients with mild VUR confers clinical benefit
Severity of ANH does not correlate with the grade of reflux and patients with VUR may have
normal postnatal ultrasound
VOIDING CYSTOURETHROGRAPHY
VCUG be restricted to patients with moderate to severe AHN (APD >10mm ; SFU grade 3-4) or ureteric
dilatation at 4-6 weeks of age
VCUG should be performed early within 24-72 hours of life, to the patients with suspected lower urinary
tract obstruction
VCUG should be performed to the patients with AHN who developed UTI
VCUG is also required in patients with history of milder grades of ANH who show worsening HN, progressive
parenchymal thinning
UPJO should be considered in infants with AHN when dilating VUR is excluded
Diuretic renography preferably with MAG3 should be performed to the infants with moderate to severe HN (SFU
grade 3-4, APD >10 mm) who do not have VUR at 6-8 weeks of age
Infants with HN s who do not have VUR should also undergo diuretic renography
Patients with VUR who had worsening HN should be evaluated for UPJO because both may coexist
DIURETIC RENOGRAPHY
DIURETIC RENOGRAPHY
Normal
An early peak (2-5 min.), rapidly descending phase and
almost complete renal emptying by 20 min.
Non-obstructive HN
Satisfactory drainage spontaneously,
or following IV frusemide and micturition
Obstructive HN
An ascending or plateau phase over 20 minutes,
that fails to empty following IV frusemide and
on post-micturition views
ANTENATAL HYDRONEPHROSIS
DIURETIC RENOGRAPHY
The risk of UTI increases with degree of HN (8% with mild HN vs 20% of moderate or severe HN)
Literature included limited data to support the proposed protective effect of antibiotic prophylaxis
A significant benefit was demonstrated in infants with high-grade HN who were given prophylaxis
as compared with those who were not
Parents should be informed about the risk of UTI and need for prompt management
Infants with moderate or severe HN (SFU 3-4; renal APD >10 mm) or dilated ureter should receive antibiotic
prophylaxis during evaluation
All patients with VUR were recommended to receive antibiotic prophylaxis through the first year of life
Infants with lower urinary tract obstruction should be immediately referred to a surgeon for appropriate
intervention
Surgery should be considered in patients with obstructed HN and either reduced differential renal
function or its worsening on repeat evaluation
Voiding Cystouretrography
No intervention